Data & Technology

There are a slew of specialist and boutique companies set up to provide high quality services and to meet the changing needs of the pharma industry.

With new tech acquisition, the software company also introduces a new branded AI assistant for mobile devices specifically for the life sciences sector.

Exagamglogene autotemcel (exa-cel) has shown the potential to be a landmark therapy in preventing episodes of excruciating pain among patients with sickle cell disease.

How drugmakers can better harness real-world evidence to drive their clinical and commercial objectives, while also providing greater clarity for healthcare providers and improved access to therapy for the patients they serve.

A breakdown on the decision, and how to navigate these obstacles using a network approach.

Conference hosts roundtable chats, with topics ranging from data-driven decision making to cold chain logistics.

Panel discusses how digital transformation can best impact supply chains.

A look into ways to approach change management using three factors.

A panel at the recent Talk Health event in Philadelphia focused on what success looks like in audio from publisher, vendor, and HCP perspectives.

Alexion – AstraZeneca Rare Disease, GSK, Novartis, Pfrizer, and Zoetis will join the newly established life sciences platform.

In the midst of providing DSCSA support, the SaaS provider is awarded for being a fast-growing, private US company.

H1 Mobile to offer latest information and research in multiple fields.

Citing growth as contributing factor, SaaS provider plans on relocating to a biopharma hub in Waltham, MA.

MIT’s Barbara Wixom, PhD, outlines the importance of data-powered research in producing financial success.

Agreement is expected to help improve the medication delivery process for patients.

Software allows pharmacies to meet legislation’s upcoming Nov. 27 deadline.

The legislation’s deadline for compliance is knocking on the door. Pharma Commerce offers a synopsis of how the Drug Supply Chain Security Act has progressed over the past decade.

In this latest Harvard Business School Healthcare Alumni Association Q&A, Ayelet Israeli, PhD, explains the potential—as well as limitations—of these offerings and pragmatic guardrails for deployment in organizations.

Using AI and data science, ‘plai’ is expected to assist employees with making everyday decisions, including the manufacturing of vaccines.

Biopharmas are able to industry insight to assist them across the end-to-end product lifecycle.

Software company’s branded orchestration platform helps to track chain of identity and chain of custody.

While generics and adherence challenges are keeping drugmakers up at night, breakthroughs in the pipeline coupled with innovative uses of artificial intelligence and machine learning techniques are bringing optimism to the cardiovascular disease space.

The latest IT offerings for sales force automation—including new AI tools—promise a more effective pharma sales process.

How pharma can harness digitalization all the way through commercialization

In effort to authenticate doctors’ information, AI-powered product strives to not only improve compliance, but also increase satisfaction among members and providers.